Canopy Growth (TSX:WEED): Is the Next Stop for This Marijuana Stock $30?

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) stock’s recent plunge may have more room to run. Find out why.

| More on:

It has been quite a slippery slope for Canopy Growth (TSX:WEED)(NYSE:CGC) stock since late April. After hitting a record high that month, its shares have fallen more than 35% since then.

After a powerful rally during the early part of the year, the sell-off in marijuana sector has been drastic since April. Horizon Marijuana Life Sciences Index, for example, has fallen more than 25% since April 29.

So, what’s causing a sudden change in heart on the part of investors who have suddenly started to hate these market darlings? In my view, there are two main reasons behind the current sell-off.

First, there is still a considerable amount of uncertainty about the future outlook of marijuana producers. Investors were certainly not happy when Canopy Growth lost $323 million in the quarter ended March 31. This big loss prompted the company’s biggest shareholder, Constellation Brands, which owns about 36% of Canopy and holds a majority of its board seats, to ask the company’s CEO to leave.

After Canopy’s disappointing earnings, investors started to realize that they are probably expecting too much from these nascent players who are still working to put their act together. That collective thinking led to revaluation of weed stocks, thus prompting this massive sell-off.

Back-to-back setbacks

The other reason that made many investors think about their marijuana holdings after the Canadian regulator found out this month that CannTrust Holdings grew pot in unlicensed rooms and provided “false and misleading” information to inspectors. 

As its share plunged, CannTrust halted all sales and shipments of its products, and the Canadian government may suspend or even cancel its licence in response. The breach led to the firing of his CEO and erased almost $500 million in market value.

These two back-to-back setbacks have shattered investor confidence in the Canadian marijuana space, especially when achieving profitability is uncertain and many players are struggling to show that they have overcome the teething problems. 

Bottom line

I think this bearish spell will continue for weed stocks in the third quarter, as investors re-evaluate their risk and book profits after a massive rally of this year. If you plan to take an advantage of these beaten-down prices, stick with the big names such as Canopy Growth. The stock will come back sooner or later.

Fool contributor Haris Anwar has no position in the stocks mentioned in this report.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »